12:00 AM
 | 
Sep 29, 2008
 |  BC Week In Review  |  Company News  |  Deals

CytRx, Innovive Pharmaceuticals deal

CytRx completed its previously announced acquisition of Innovive for about 2.6 million shares valued at $1.5 million based...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >